Stay updated on Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The screenshots show only minor UI differences with no substantive changes to core trial data (e.g., status, eligibility, or location details). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T01:14:08.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    36 days ago
    Change Detected
    Summary
    Introducing a government funding lapse notice and an updated software version (v3.2.0); removing the previous version tag (v3.1.0).
    Difference
    8%
    Check dated 2025-10-05T10:07:08.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:13:22.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Updated to revision v3.0.2; indicates a new release with unspecified changes. The 'Back to Top' option was removed, a minor UI change.
    Difference
    0.5%
    Check dated 2025-09-13T17:36:46.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.5%
    Check dated 2025-09-06T15:04:42.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.
    Difference
    76%
    Check dated 2025-08-30T11:51:50.000Z thumbnail image

Stay in the know with updates to Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.